TrialThe Journal of infectious diseases2013

Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.

Andrew Mujugira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.